Brief: Lee's Pharmaceutical Holdings Posts QTRLY Revenue HK$282.9 MLN
30/05/2019 11:09
May 30 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY REVENUE HK$282.9 MILLION VERSUS HK$281.9 MILLION
* QTRLY PROFIT ATTRIBUTABLE HK$47 MILLION VERSUS HK$70.2
MILLION
Source text for Eikon: ID:nHKS9nskcL
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA